- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
ECYT
Why Endocyte, Inc. (ECYT) Stock Is Going Bonkers Today
Endocyte (ECYT) shares soared nearly 50% early Tuesday as the company unveiled the results of a new treatment for a type of prostate cancer.
16 Pharmaceuticals Stocks to Sell Now
The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
26 Pharmaceuticals Stocks to Sell Now
The ratings of 26 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
14 Pharmaceuticals Stocks to Sell Now
This week, the ratings of 14 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
16 Pharmaceuticals Stocks to Sell Now
This week, the overall grades of 16 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
12 Pharmaceuticals Stocks to Sell Now
This week, the overall grades of 12 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Buy Now
The grades of three Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").